Related Experiment Video

Updated: Mar 24, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Toxin Immunoassays and Clostridium difficile Infection-Reply

Christopher R Polage1, Jay V Solnick2, Stuart H Cohen3

  • 1Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine, Sacramento, California2Division of Infectious Diseases, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, Cal.

JAMA Internal Medicine
|March 9, 2016
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

21.4K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K
Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples
08:00

Enrichment and Detection of Clostridium perfringens Toxinotypes in Retail Food Samples

Published on: October 18, 2019

21.4K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

21
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
21
Bacterial Toxins01:12

Bacterial Toxins

30
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
30

Articles linked to this work by shared authors, journal, and citation graph.

Fosmanogepix treatment for coccidioidomycosis under an expanded access program.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

An approach to Candidozyma auris surveillance in a low prevalence setting.

American journal of infection control·2025

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection.

The Journal of infectious diseases·2025

NCCN Guidelines® Insights: Survivorship, Version 2.2025.

Journal of the National Comprehensive Cancer Network : JNCCN·2025

Risk factors for the development of Clostridioides difficile infection in patients colonized with toxigenic Clostridioides difficile.

Infection control and hospital epidemiology·2025

Quality, Cost, and Timeliness of Cancer Treatment in Medicare Advantage and Traditional Medicare.

JAMA internal medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us